EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
MIRA Pharmaceuticals, Inc. (MIRA) EBIT Margin data is not available.
| Income Statement Financials | |
-- |
|
$-1.54M |
|
-- |
|
-- |
|
$1.55M |
|
$-1.55M |
|
$0.01M |
|
$-1.54M |
|
$-1.54M |
|
$-1.54M |
|
$-1.54M |
|
$-1.54M |
|
$-1.54M |
|
$-1.55M |
|
$-1.55M |
|
16.99M |
|
16.99M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$0.83M |
|
-- |
|
$0.04M |
|
$0.87M |
|
$0.30M |
|
-- |
|
-- |
|
$0.30M |
|
$0.57M |
|
$0.57M |
|
$0.57M |
|
17.39M |
|
| Cash Flow Statement Financials | |
$-2.43M |
|
-- |
|
$0.33M |
|
$2.83M |
|
$0.73M |
|
$-2.10M |
|
$1.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.79 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
EBIT Margin |
-- |
-- |
|
-- |
|
-- |
|
$-2.43M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-269.84% |
|
-269.84% |
|
-177.09% |
|
-269.84% |
|
$0.03 |
|
$-0.14 |
|
$-0.14 |
|